aclacinomycins: Clinical Trials

9 trials of aclacinomycins, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 2 completed, 2 recruiting. 4 Phase 2, 2 Not applicable, 2 Phase 3, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Unknown 2
Not applicable2Unknown 2
Phase 32Recruiting 2
Phase 11Completed 1
Phase 41Unknown 1

Follow aclacinomycins: new trials by email Literature Review of aclacinomycins trials Research Report on aclacinomycins

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia
the standard "3+7" regimen, Azacytidine; Cytarabine; Aclacinomycin; Chidamide; Venetoclax; Granulocyte - Newly Diagnosed Acute Myeloid Leukemia (AML), Elderly Patients
Phase 3RecruitingChinese PLA General Hospital1202024-11-182026-08-20
Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients
Selinexor, Homoharringtonine, Cytarabine - Relapsed/Refractory AML
Not applicableUnknownThe First Affiliated Hospital of Soochow University202023-05-012023-05-06
Venetoclax Combined With Azacitidine and CAG in Refractory/Relapse Acute Myeloid Leukemia
Venetoclax - Refractory/Relapse Acute Myeloid Leukemia
Phase 2UnknownHematology department of the 920th hospital422023-02-012023-04-11
Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia
Selinexor, Homoharringtonine, Daunorubicin - Relapsed or Refractory Acute Myeloid Leukemia
Phase 3RecruitingShanxi Bethune Hospital502023-01-292024-10-22
Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)
Decitabine, Daunorubicin, Cytarabine, Mitoxantrone, Cytarabine - Acute Myeloid Leukemia
Phase 4UnknownThe First Hospital of Jilin University1802017-01-012017-01-20
Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia
Cladribine, G-CSF, Aclarubicin - Acute Myeloid Leukemia, Relapse Leukemia
Phase 2UnknownSun Yat-sen University482016-01-012019-08-20
Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old
CAG regimen (Aclacinomycin, cytarabine, with/w/o G-CSF), low dose cytarabine - Acute Myeloid Leukemia
Not applicableUnknownJianxiang Wang3002015-04-012016-10-07
Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML
Decitabine 20 mg/m²/day for 5 days - AML
Phase 2CompletedChinese PLA General Hospital302015-04-012019-06-10
Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML)
Decitabine, Cytarabine, aclacinomycin - MDS, AML
Phase 1 / Phase 2CompletedChinese PLA General Hospital292012-11-012016-02-25

Conditions studied

Leukemia, Myeloid, Acute (6)  ·  Recurrence (1)

Sponsors

Chinese PLA General Hospital (3)  ·  Hematology department of the 920th hospital (1)  ·  Jianxiang Wang (1)  ·  Shanxi Bethune Hospital (1)  ·  Sun Yat-sen University (1)  ·  The First Affiliated Hospital of Soochow University (1)  ·  The First Hospital of Jilin University (1)

Countries

China (9)

Top investigators

Dahong Liu, Doctor (1)  ·  Li Yu, M.D. Ph.D. (1)  ·  Liang Wang, M.D. (1)  ·  Su J Gao, PhD (1)  ·  Tao Wang (1)

Results publications

PMID 28881839